Esperion Therapeutics, Inc.（ESPR）内部人交易：高管与董事近期交易
过去 18 个月，共有 11 位内部人为 Esperion Therapeutics, Inc.（ESPR）报告了 44 笔 Form 4 交易（最近一笔 2026-07-13）。
| 日期 | 内部人 | 职务 | 类型 | 股数 | 市值 |
|---|---|---|---|---|---|
| 2026-07-13 | CARROLL J MARTIN | 董事 | 卖出 | 177,523 | $0 |
| 2026-07-13 | Shepard Jay | 董事 | 卖出 | 164,472 | $0 |
| 2026-07-13 | THOMPSON JOHN CRAIG | 董事 | 卖出 | 79,873 | $0 |
| 2026-07-13 | Fischer Seth H. Z. | 董事 | 卖出 | 141,023 | $0 |
| 2026-07-13 | Hoffman Robert E. | 董事 | 卖出 | 85,153 | $0 |
| 2026-07-13 | Koenig Sheldon L. | President and CEO | 卖出 | 2.1M | $0 |
| 2026-07-13 | Looker Benjamin | Chief Legal Officer | 卖出 | 667,524 | $0 |
| 2026-07-13 | Halladay Benjamin | Chief Financial Officer | 卖出 | 705,410 | $0 |
| 2026-07-13 | Harlow John B. Jr. | Chief Commercial Officer | 卖出 | 424,536 | $0 |
| 2026-06-18 | Looker Benjamin | Chief Legal Officer | 卖出 | 11,824 | $37,364 |
| 2026-06-18 | Halladay Benjamin | Chief Financial Officer | 卖出 | 10,773 | $34,043 |
| 2026-06-18 | Koenig Sheldon L. | President and CEO | 卖出 | 53,588 | $169,338 |
| 2026-06-01 | THOMPSON JOHN CRAIG | 董事 | 买入 | 79,873 | $0 |
| 2026-06-01 | CARROLL J MARTIN | 董事 | 买入 | 79,873 | $0 |
| 2026-06-01 | Fischer Seth H. Z. | 董事 | 买入 | 79,873 | $0 |
| 2026-06-01 | Shepard Jay | 董事 | 买入 | 79,873 | $0 |
| 2026-06-01 | Hoffman Robert E. | 董事 | 买入 | 79,873 | $0 |
| 2026-03-18 | Looker Benjamin | Chief Legal Officer | 卖出 | 5,708 | $15,412 |
| 2026-03-18 | Halladay Benjamin | Chief Financial Officer | 卖出 | 6,424 | $17,409 |
| 2026-03-18 | Koenig Sheldon L. | President and CEO | 卖出 | 25,578 | $69,572 |
| 2026-03-16 | Koenig Sheldon L. | President and CEO | 买入 | 723,760 | $0 |
| 2026-03-16 | Halladay Benjamin | Chief Financial Officer | 买入 | 247,430 | $0 |
| 2026-03-16 | Looker Benjamin | Chief Legal Officer | 买入 | 300,840 | $0 |
| 2026-01-21 | Looker Benjamin | General Counsel | 卖出 | 1,689 | $4,864 |
| 2025-12-18 | Halladay Benjamin | Chief Financial Officer | 卖出 | 7,337 | $26,927 |
来源：SEC Form 4 申报文件 · 截至 2026-07-13